Fig. 5. Distribution of the risk score, survival status, and expression of the six m⁶A-related lncRNAs in the training and validation groups of HCC.

(A–B) Proportions of death in the high- and low-risk groups of the training and validation cohorts. (C–D) Risk maps of the risk score, survival status, and expression of lncRNAs in the training and validation cohorts. HCC, hepatocellular carcinoma; lncRNAs, long noncoding RNAs; m⁶A, N6-methyladenosine; TCGA, The Cancer Genome Atlas.